Mucodel Pharma Announces Patent Allowance for Mucodel’s Co-Gel Buccal Naloxone (Exonal™)
15 mars 2017 07h45 HE
|
Mucodel Pharma LLC
Greensboro, NC, March 15, 2017 (GLOBE NEWSWIRE) -- Mucodel Pharma LLC (“Mucodel”) announced today that it has received a notice of allowance from the United States Patent and Trademark Office for...
Mucodel Pharma Announces Successful Completion of Buccal Naloxone Pilot Clinical Study
21 sept. 2016 07h45 HE
|
Mucodel Pharma LLC
GREENSBORO, N.C., Sept. 21, 2016 (GLOBE NEWSWIRE) -- Mucodel Pharma LLC (“Mucodel”) today announced the successful completion of a pilot clinical study involving buccal naloxone (Exonal™), a...
Lightlake Therapeutics Inc.Announces Adapt Pharma Limited to Offer All U.S. High Schools a Free Narcan® (Naloxone Hydrochloride) Nasal Spray and Fund School-Based Opioid Overdose Education
27 janv. 2016 09h00 HE
|
Opiant Pharmaceuticals, Inc.
NEW YORK, Jan. 27, 2016 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...
Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Facilitates NARCAN® (Naloxone Hydrochloride) Nasal Spray Access to 62,000 State and Local Public Entities
19 janv. 2016 09h00 HE
|
Opiant Pharmaceuticals, Inc.
NEW YORK, Jan. 19, 2016 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...
Lightlake Therapeutics Inc. Receives Milestone Payment for U.S. Food and Drug Administration Approval of NARCAN(R) (Naloxone Hydrochloride) Nasal Spray
15 déc. 2015 09h00 HE
|
Opiant Pharmaceuticals, Inc.
NEW YORK, Dec. 15, 2015 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...
BioCorRx, Inc. and MyLife Recovery CentersTM Announce Availability of the Start Fresh Program(r) for Treating Addiction in Washington, D.C.
09 mars 2015 07h00 HE
|
BioCorRx
Los Angeles, March 9, 2015 (GLOBE NEWSWIRE) -- BioCorRx,
Inc. (BICX), developer of the Start Fresh Program,
announces the opening of a new center offering the program in
Washington D.C. by its...
BioCorRx, Inc. Enters Agreement with Former Bosley, Inc. CEO and Medical Marketing Experts to Assist in Acquisition and Operation of Management Company
09 déc. 2014 08h00 HE
|
BioCorRx
Los Angeles, Dec. 9, 2014 (GLOBE NEWSWIRE) -- BioCorRx, Inc.
(BICX), developer of the Start Fresh Program®, announced today that
the company has entered into an agreement with EROI, LLC., which...
BioCorRx, Inc. Announces Availability of its Start Fresh Program for Treating Addiction in Oklahoma City, Oklahoma
04 déc. 2014 13h51 HE
|
BioCorRx
Los Angeles, Dec. 4, 2014 (GLOBE NEWSWIRE) -- BioCorRx,
Inc. (BICX), developer of the Start Fresh Program®,
announces expansion into Oklahoma with the opening of a Start Fresh
Recovery...